Literature DB >> 2115516

NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.

G P Kurzban1, J Howarth, G Palmer, H W Strobel.   

Abstract

NADPH-cytochrome P-450 reductase contains one molecule each of FMN and FAD. The FAD moiety has been selectively removed, producing the FMN reductase. The FMN reductase is stable and enzymatic activity is reconstituted with either FAD or FMN. FMN remains tightly bound, but can both dissociate from the FMN site and bind to the vacant FAD site. The amount of FMN bound in the FAD site is minimal under specific experimental conditions. There are at least two conformational subpopulations of the FMN reductase; NADP dissociates readily from one but extremely slowly from the other. Rapid dissociation of NADP is regained upon reconstitution with FAD. The one-electron redox state of the FMN reductase is thermodynamically stabilized, though to a lesser degree than in the holoreductase. When two-electron reduced FMN reductase is exposed to oxygen, a stable species with an absorbance peak at 580 nm forms rapidly and quantitatively. This species has been identified by electron paramagnetic resonance spectroscopy as the neutral radical of FMN and is indistinguishable from the air-stable radical of the holoreductase. The redox behavior of the FMN reductase is in agreement with properties proposed previously for the FMN site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115516

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Short-lived neutral FMN and FAD semiquinones are transient intermediates in cryo-reduced yeast NADPH-cytochrome P450 reductase.

Authors:  Roman M Davydov; Gareth Jennings; Brian M Hoffman; Larissa M Podust
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

2.  Novel Substrate Specificity and Temperature-Sensitive Activity of Mycosphaerella graminicola CYP51 Supported by the Native NADPH Cytochrome P450 Reductase.

Authors:  Claire L Price; Andrew G S Warrilow; Josie E Parker; Jonathan G L Mullins; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

3.  Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.

Authors:  G C Smith; D G Tew; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

4.  High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.

Authors:  Duanpen Sandee; Walter L Miller
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

5.  1H, 15N and 13C NMR resonance assignment, secondary structure and global fold of the FMN-binding domain of human cytochrome P450 reductase.

Authors:  I Barsukov; S Modi; L Y Lian; K H Sze; M J Paine; C R Wolf; G C Roberts
Journal:  J Biomol NMR       Date:  1997-07       Impact factor: 2.835

6.  Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.

Authors:  Michel Kranendonk; Christopher C Marohnic; Satya P Panda; Maria Paula Duarte; José Santos Oliveira; Bettie Sue Siler Masters; José Rueff
Journal:  Arch Biochem Biophys       Date:  2008-04-20       Impact factor: 4.013

Review 7.  Nitrite as regulator of hypoxic signaling in mammalian physiology.

Authors:  Ernst E van Faassen; Soheyl Bahrami; Martin Feelisch; Neil Hogg; Malte Kelm; Daniel B Kim-Shapiro; Andrey V Kozlov; Haitao Li; Jon O Lundberg; Ron Mason; Hans Nohl; Tienush Rassaf; Alexandre Samouilov; Anny Slama-Schwok; Sruti Shiva; Anatoly F Vanin; Eddie Weitzberg; Jay Zweier; Mark T Gladwin
Journal:  Med Res Rev       Date:  2009-09       Impact factor: 12.944

8.  Expression, Purification, and Biochemical Characterization of the Flavocytochrome P450 CYP505A30 from Myceliophthora thermophila.

Authors:  George J Baker; Hazel M Girvan; Sarah Matthews; Kirsty J McLean; Marina Golovanova; Timothy N Waltham; Stephen E J Rigby; David R Nelson; Richard T Blankley; Andrew W Munro
Journal:  ACS Omega       Date:  2017-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.